Literature DB >> 989265

Experimental studies on the positive feedback effect of progesterone, 17 alpha-hydroxyprogesterone and 20 alpha-dihydroprogesterone on the pituitary release of LH and FSH in the human female. The estrogen priming of the progesterone feedback on pituitary gonadotropins in the eugonadal woman.

G Leyendecker, L Wildt, H Gips, W Nocke, E J Plotz.   

Abstract

Administration of progesterone eugonadal women during the midfollicular phase of the menstrual cycle failed to induce a positive feedback effect on the serum concentrations of LH and FSH. The levels of estradiol in serum decreased following the injection of progesterone without a parallel change in LH and FSH concentrations indicating a direct ovarian effect of the exogenous progesterone. In the late follicular phase of the cycle, when preovulatory levels of estradiol were present in serum, or under a ethinyl estradiol treatment progesterone was able to induce an LH discharge indicating the requirement of an estradiol priming of the positive feedback of progesterone in eugonadal women. In order to establish the time required for a sufficient estrogen priming with preovulatory levels of estradiol in serum 3 mg of estradiol-benzoate were administered i.m. 1, 12 and 24 h prior to the administration of 30 mg of microcristalline progesterone in the midfollicular phase of the menstrual cycle, when progesterone alone did not cause an LH surge. Only when estradiol-benzoate was injected 24 h prior to the progesterone administration an LH surge reproducible in time course and magnitude occurred. Administration of estradiol-benzoate alone under these conditions did not cause an LH surge within the elapse of time after the injection when the progesterone induced LH surge occurred. Thus, these experiments demonstrate that a defined estrogen priming is required for the positive feedback effect of progesterone on the gonadotropin release in eugonadal women. Furthermore, progesterone levels in serum of about only 1--2 ng/ml were required for the induction of an LH surge indicating that under physiological conditions progesterone may have an supplementory effect on the primarily estradiol induced LH midcycle peak. 17-hydroxyprogesterone administered during the mid follicular phase of the menstrual cycle and under pretreatment with ethinyl estradiol failed to induce a positive feedback effect on the serum concentrations of LH and FSH, indicating that this steroid does not play a regulatory role on the midcycle LH release in women. 20alpha-dihydroprogesterone administered under the same experimental conditions as 17-hydroxyprogesterone seems to be able to induce an LH surge in serum provided there is an adequate estrogen priming.

Entities:  

Keywords:  Biology; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Endocrine System; Estradiol; Estradiol Benzoate; Estrogens; Ethinyl Estradiol; Evaluation; Evaluation Methodology; Family Planning; Feedback; Gonadotropins; Gonadotropins, Pituitary; Hormones; Human Volunteers; Luteinizing Hormone--analysis; Physiology; Progestational Hormones; Progesterone--side effects; Research Methodology

Mesh:

Substances:

Year:  1976        PMID: 989265     DOI: 10.1007/bf00667679

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


  28 in total

1.  Observations on facilitation of the preovulatory rise of LH by estrogen.

Authors:  S P Kalra
Journal:  Endocrinology       Date:  1975-01       Impact factor: 4.736

2.  THE INFLUENCE OF GESTAGENS ON THE URINARY EXCRETION OF PITUITARY GONADOTROPINS, ESTROGENS, AND PREGNANEDIOL IN WOMEN IN THE POSTMENOPAUSE AND DURING THE MENSTRUAL CYCLE.

Authors:  R BUCHHOLZ; L NOCKE; W NOCKE
Journal:  Int J Fertil       Date:  1964 Jan-Mar

3.  Measurement of serum LH, FSH, progesterone, 17-hydroxy-progesterone and estradiol-17beta levels at 4-hour intervals during the periovulatory phase of the menstrual cycle.

Authors:  I H Thorneycroft; B Sribyatta; W K Tom; R M Nakamura; D R Mishell
Journal:  J Clin Endocrinol Metab       Date:  1974-10       Impact factor: 5.958

4.  Gamma globulin protection of radioimmunoassay and competitive protein binding saturation analysis of steroids.

Authors:  G Leyendecker; S Wardlaw; W Nocke
Journal:  J Clin Endocrinol Metab       Date:  1972-02       Impact factor: 5.958

5.  Plasma 20alpha-hydroxypregn-4-en-3-one in the normal menstrual cycle.

Authors:  C H Wu; L Prazak; G L Flickinger; G Mikhail
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

6.  Temporal interrelationships among circulating levels of estradiol, progesterone and LH during the rat estrous cycle: effects of exogenous progesterone.

Authors:  S P Kalra; P S Kalra
Journal:  Endocrinology       Date:  1974-12       Impact factor: 4.736

7.  The effects of progesterone on the patterns of testosterone and estradiol concentrations in the systemic plasma of the female rhesus monkey during the intermenstrual period.

Authors:  D L Hess; J A Resko
Journal:  Endocrinology       Date:  1973-02       Impact factor: 4.736

8.  The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.

Authors:  B L Lasley; C F Wang; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

Review 9.  On the control of gonadotropin secretion in the rhesus monkey.

Authors:  E Knobil
Journal:  Recent Prog Horm Res       Date:  1974

10.  [LH, FSH and ovarian steroids in serum during normal menstrual cycles and cycles with corpus luteum insufficiency in the human female (author's transl)].

Authors:  G Leyendecker; K Hinckers; W Nocke; E J Plotz
Journal:  Arch Gynakol       Date:  1975
View more
  3 in total

1.  The mechanism of action of a new low-dosed combined oral contraceptive.

Authors:  J S Dericks-Tan; K Schneider; H D Taubert
Journal:  Arch Gynecol       Date:  1980

2.  Ovarian influence on gonadotropin and prolactin release in mated rabbits.

Authors:  C Y Pau; K Y Pau; M Berria; H G Spies
Journal:  Endocrine       Date:  2000-08       Impact factor: 3.633

3.  Plasma levels of FSH and LH in patients with gonadal dysgenesis during sequential estrogen and progestogen therapy.

Authors:  M Breckwoldt; H Roll; H P Zahradnik; K Amann; G Reck; F Peters
Journal:  Arch Gynecol       Date:  1980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.